This study provides evidence that fully closed-loop insulin delivery can improve glucose control and reduce hypoglycemia compared to standard insulin therapy in adults with type 2 diabetes and ESRD requiring dialysis, in an unrestricted home setting. The gene discussed is INS; the disease is type 2 diabetes mellitus.